Impact of febrile neutropenia on R-CHOP chemotherapy delivery and hospitalizations among patients with diffuse large B-cell lymphoma

PURPOSE: This analysis from an observational study of clinical practice describes the impact of febrile neutropenia (FN) on chemotherapy delivery and hospitalizations. METHODS: Adults with diffuse large B-cell lymphoma (DLBCL) scheduled to receive ≥3 cycles of 2- or 3-weekly CHOP with rituximab (R-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Pettengell, Ruth, Johnson, Hans E., Lugtenburg, Pieternella J., Silvestre, Antonio Salar, Dührsen, Ulrich, Rossi, Francesca G., Schwenkglenks, Matthias, Bendall, Kate, Szabo, Zsolt, Jaeger, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2011
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271211/
https://www.ncbi.nlm.nih.gov/pubmed/22101611
http://dx.doi.org/10.1007/s00520-011-1306-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3271211/
https://www.ncbi.nlm.nih.gov/pubmed/22101611
http://dx.doi.org/10.1007/s00520-011-1306-6

Ejemplares similares